Interactions Between Food and Medications – How to Dilute Pharmaceuticals?

An orally administered pharmaceutical preparation undergoes a sophisticated sequence of biological and physicochemical transformations within the human body. Its composition includes both therapeutically active compounds and excipients that confer structural integrity—among these are solvents such as purified water, structural carriers like gelatin, and bulking agents derived from potato or corn starch. Throughout its transit across successive physiological compartments, several critical processes occur: the **release** of the active pharmaceutical ingredient from its dosage matrix, **penetration** through biological membranes into systemic circulation, **delivery** to target tissues or receptor sites, **biochemical modification** primarily in the liver or other metabolic organs, and ultimately the **elimination** of metabolites or unchanged molecules from the organism. These stages are encapsulated by the acronym **LADME**, which delineates the following phases: **L**iberation (dissociation of the active moiety from the formulation), **A**bsorption (translocation into the bloodstream), **D**istribution (dispersion throughout bodily tissues), **M**etabolism (enzymatic or chemical alteration within the body), **E**xcretion (clearance via urine, feces, or pulmonary expulsion).

According to statistical data, approximately one in every three advertisements pertains to pharmaceutical products, and it is within this context that the widely recognized disclaimer emerges: "Before use, carefully read the patient information leaflet included in the package or consult your physician or pharmacist, as improper use of the medication may pose a risk to your life or health." This mandatory notice stems from legal regulations, including those issued by the Ministry of Health, which require such warnings to be featured in all broadcast pharmaceutical advertisements. Regrettably, in clinical practice, the majority of patients only refer to the leaflet after experiencing adverse interactions—such as consuming the medication with incompatible food or beverages—resulting in discomfort or side effects. Common misuse scenarios include elderly individuals with swallowing difficulties splitting extended-release tablets, despite these formulations typically lacking a score line, meaning they must be ingested whole. Failure to adhere to these guidelines may lead to gastrointestinal irritation or compromised therapeutic efficacy. A meticulous examination of the leaflet, with particular attention to sections on drug interactions, dosage instructions, and contraindications, can significantly mitigate the risk of complications and enhance the overall safety of pharmacotherapy.

Pharmaceutical formulations exhibit distinct pharmacokinetic profiles, including variations in their primary sites of absorption—whether within the gastrointestinal tract or the stomach itself. Of paramount importance is strict adherence to the prescribing information regarding administration timing: either in a fasted state or following meal consumption. Fasting accelerates the attainment of peak plasma concentrations of the active ingredient, whereas postprandial administration delays gastric emptying, thereby prolonging the drug’s transit through the digestive system. It must be emphasized, however, that accelerated absorption does not universally correlate with enhanced therapeutic efficacy—the mechanisms of action across different pharmacological classes are highly divergent, necessitating tailored dosing regimens.